CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Multi-dose Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) with or Without Recombinant Human Interleukin-2 (rhIL-2) in Adults with Primary or Secondary Acute Myeloid Leukemia (AML) in Morphologic Complete Remission with Minimal Residual Disease (MRD) or Relapsed/refractory (R/R) AML

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04310592
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:03.080595+00:00
Published At: 2024-12-12T00:00:00+00:00
Record Updated At: 2024-12-12
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Leukemia", "Leukemia, Myeloid", "Leukemia, Myeloid, Acute", "Neoplasms by Histologic Type", "Neoplasms", "Immunosuppressive Agents", "Immunologic Factors", "Physiological Effects of Drugs", "Alkylating Agents", "Antimetabolites, Antineoplastic", "Antiviral Agents", "Analgesics, Non-narcotic", "Anti-infective Agents", "Analgesics", "Peripheral Nervous System Agents", "Hematologic Diseases", "Hematologic Neoplasms", "Leukemia in Remission", "Relapsed Adult AML", "Refractory AML"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-12-12"
protocolSection.identificationModule.nctId: "NCT04310592"
protocolSection.identificationModule.officialTitle: "A Phase I Multi-dose Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) with or Without Recombinant Human Interleukin-2 (rhIL-2) in Adults with Primary or Secondary Acute Myeloid Leukemia (AML) in Morphologic Complete Remission with Minimal Residual Disease (MRD) or Relapsed/refractory (R/R) AML"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.